Skip to main content
Symptom
dx.
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Symptom
dx.
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Get Started
Menu
Clinical Reference
Approaches
I have a symptom
Management
I know the diagnosis
Orthopedic Injuries
Fractures & dislocations
Calculators
Clinical calculators
Practical Skills
ECG
Interpretation guide
POCUS
Bedside ultrasound
Procedures
Step-by-step guides
Resuscitation
ACLS / PALS / NRP
Learn
Blog
Articles & updates
Deep Dive
In-depth clinical reviews
About
Our mission
Loading...
Staphylococcal Scalded Skin Syndrome
Cardiovascular Presentations
Abdominal aortic aneurysm
Acute coronary syndrome (NSTEMI)
Acute coronary syndrome (STEMI)
Acute decompensated heart failure
Acute limb ischemia
Acute mesenteric ischemia
Aortic dissection
Aortic stenosis
Atrial fibrillation and flutter
Bradyarrhythmia and heart block
Cardiac arrest
Deep vein thrombosis
Myocarditis
Pericarditis
Pulmonary embolism
Stable angina
Superficial thrombophlebitis
Superior vena cava syndrome
Supraventricular tachycardia
Syncope (cardiogenic)
Unstable angina
Ventricular tachycardia
Respiratory Presentations
Acute bronchitis
Acute respiratory failure
Aspiration pneumonia
Asthma exacerbation
Bronchiolitis
Community-acquired pneumonia
COVID-19 pneumonia
COPD exacerbation
Croup
Croup (laryngotracheobronchitis)
Epiglottitis
Hemothorax
Hospital-acquired pneumonia
Pleural effusion
Pneumothorax (traumatic)
Pulmonary contusion
Spontaneous pneumothorax
Neurological Presentations
Bell's palsy
Benign paroxysmal positional vertigo
Brain abscess
Cauda equina syndrome
Cervical radiculopathy
Concussion (mild traumatic brain injury)
Encephalitis
Guillain-Barré syndrome
Hemorrhagic stroke (intracerebral)
Ischemic stroke
Lumbar radiculopathy
Malignant spinal cord compression
Migraine
Peripheral neuropathy (acute)
Retropharyngeal abscess
Schizophrenia (acute exacerbation)
Seizure (breakthrough:known epilepsy)
Seizure (first-time)
Spinal cord injury
Status epilepticus
Subarachnoid hemorrhage
Tension headache
Transient ischemic attack
Traumatic brain injury (moderate-severe)
Vestibular neuritis
Viral meningitis
Gastrointestinal Presentations
Acute appendicitis
Acute cholecystitis
Acute diverticulitis
Acute pancreatitis
Anal fissure
Choledocholithiasis and cholangitis
Clostridioides difficile colitis
Gastritis
Gastroenteritis (viral and bacterial)
Gastroesophageal reflux disease
Incarcerated or strangulated hernia
Inflammatory bowel disease flare
Large bowel obstruction
Lower GI hemorrhage
Peptic ulcer disease
Perforated viscus
Small bowel obstruction
Upper GI hemorrhage
Genitourinary and Reproductive Presentations
Acute prostatitis
Acute urinary retention
Ectopic pregnancy
Epididymitis
Orchitis
Ovarian torsion
Paraphimosis
Pelvic inflammatory disease
Priapism
Pyelonephritis
Renal laceration
Ruptured ovarian cyst
Testicular torsion
Tubo-ovarian abscess
Urinary tract infection (uncomplicated)
Urolithiasis (renal colic)
Vaginal bleeding (non-pregnant)
Infectious Disease Presentations
Acute sinusitis
Acute tonsillitis
Acute upper respiratory infection
Animal bite
Bacterial meningitis
Cellulitis
Conjunctivitis (bacterial)
Dental abscess
Endocarditis
Febrile neutropenia
Fournier gangrene
Hand-foot-mouth disease
Hepatitis (acute)
Herpes zoster
HIV-related illness
Human bite
Impetigo
Infected diabetic foot ulcer
Infectious mononucleosis
Influenza
Necrotizing fasciitis
Osteomyelitis
Otitis externa
Parasitic infection
Periorbital cellulitis
Peritonsillar abscess
Scabies
Sepsis
Septic arthritis
Spontaneous bacterial peritonitis
Tick-borne illness (Lyme disease)
Tinea infection
Tuberculosis
Viral exanthem
Wound infection
Trauma Presentations
Achilles tendon rupture
ACL and mceniscus tear
Ankle fracture
Ankle sprain
Burn
Calcaneus fracture
Cervical spine fracture
Clavicle fracture
Dental avulsion
Distal radius fracture
Drowning
Elbow fracture and dislocation
Electrical injury
Facial bone fracture
Facial laceration
Femur fracture
Fingertip amputation
Forearm fracture (radius and ulna)
Frostbite
Hand:finger laceration
Heat exhaustion
Heat stroke
Hip fracture
Humeral shaft fracture
Knee dislocation
Knee sprain
Lightning injury
Mandible fracture
Metacarpal fracture
Metatarsal fracture
Muscle strain
Nasal fracture
Non-accidental trauma
Orbital fracture
Patella fracture
Phalanx fracture (finger)
Proximal humerus fracture
Pulmonary contusion
Rib fracture
Rotator cuff tear (acute traumatic)
Scalp laceration
Scaphoid fracture
Shoulder dislocation
Skull fracture
Splenic laceration
Sternal fracture
Supracondylar pediatric fracture
Tendon laceration (hand:wrist)
Thoracic and lumbar spine fracture
Tibia:fibula fracture
Tibial plateau fracture
Toe fracture
Traumatic epistaxis
Traumatic hyphema
Toxicologic Presentations
Acetaminophen toxicity
Alcohol intoxication
Alcohol withdrawal
Anticholinergic toxicity
Anticoagulant overdose
Benzodiazepine overdose
Benzodiazepine:sedative overdose
Beta-blocker and calcium channel blocker toxicity
Carbon monoxide poisoning
Caustic ingestion
Digoxin toxicity
Drug eruption
Foreign body ingestion
Opioid intoxication
Opioid overdose
Opioid withdrawal
Organophosphate
Salicylate toxicity
Serotonin syndrome
Stimulant intoxication (cocaine, methamphetamine)
Tricyclic antidepressant overdose
Psychiatric Presentations
Acute anxiety
Acute psychosis
Agitation:behavioral emergency
Bipolar disorder
Conversion disorder
Major depressive episode
Neuroleptic malignant syndrome
Suicidal ideation and attempt
Musculoskeletal and Rheumatologic Presentations
Acute low back pain (mechanical)
Bursitis
Cervical radiculopathy
Costochondritis
Gout (acute)
Lumbar radiculopathy
Pseudogout
Tendinitis
Dermatology Presentations
Acute eczema (Eczema acute flare)
Allergic contact dermatitis
Erythema multiforme
Henoch-Schönlein purpura
Pressure injury
Psoriasis (acute flare)
Stevens-Johnson syndrome
Toxic epidermal necrolysis
Urticaria (acute)
Environmental and Exposure Presentations
Envenomation (snake, spider, insect)
High-altitude illness
Hypothermia
Hematologic and Oncologic Presentations
Acute chest syndrome
Coagulopathy
Hyperviscosity syndrome
Sickle cell crisis (vaso-occlusive)
Symptomatic anemia
Thrombocytopenia (severe)
Tumor lysis syndrome
Pediatric-Specific Presentations
Bronchiolitis
Croup
Emergency delivery
Febrile seizure
Kawasaki disease
Neonatal jaundice
Neonatal sepsis
Nursemaid's elbow
Pediatric fever 0 to 28 days
Pediatric fever 29 to 60 days
Pediatric fever 61 to 90 days
Pyloric stenosis
Slipped capital femoral epiphysis
Intussusception
Endocrine and Metabolic Presentations
Adrenal crisis
Diabetic ketoacidosis
Hypercalcemia
Hyperosmolar hyperglycemic state
Hypertensive emergency
Hypertensive urgency
Hypoglycemia
Myasthenia gravis crisis
Myxedema coma
Severe hyperkalemia
Severe hyponatremia
Thyroid storm
ENT and Maxillofacial Presentations
Acute laryngitis
Acute otitis media
Acute pharyngitis
Cerumen impaction
Epistaxis (anterior)
Nasal foreign body
Otitis externa
Tympanic membrane perforation
Ophthalmologic Presentations
Acute angle-closure glaucoma
Central retinal artery occlusion
Chemical eye injury
Corneal abrasion
Corneal ulcer
Globe rupture
Ocular foreign body
Orbital cellulitis
Retinal detachment
Obstetric Presentations
Hyperemesis gravidarum
Painful vaginal bleeding in pregnancy
Placenta previa
Placental abruption
Preeclampsia:eclampsia
Preterm labor
Threatened:inevitable:incomplete abortion
Systemic and Miscellaneous Presentations
Anaphylaxis
Angioedema
Cannabis-induced hyperemesis
Staphylococcal Scalded Skin Syndrome
POCUS
Procedures
Calculators
Resuscitation
ECG Guide
Back
Clinical Assessment Checklist
Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate priorities
Skin failure recognition
▶
Extensive desquamation with large body surface area involvement
▶
Significant insensible fluid losses resembling burn physiology
Temperature dysregulation from barrier loss
Signs of secondary sepsis
▶
Tachycardia, hypotension, or altered mental status
Lactate >= 2 mmol/l or signs of organ dysfunction
Neonatal high-risk features
▶
Age < 1 month with diffuse skin involvement
Hypothermia or feeding intolerance
Stabilization priorities
▶
Secure IV access early
▶
Avoid denuded skin for line insertion
Umbilical venous catheter in neonates when peripheral access fails
Initiate IV antibiotics within 1 hour if sepsis features present
▶
Class I recommendation
Anti-staphylococcal beta-lactam as first-line
Fluid resuscitation for burn-like losses
▶
IV crystalloid if oral intake insufficient
Maintenance plus replacement for losses through denuded skin
Key diagnostic branch point
▶
Mucosal involvement present
▶
Raises concern for toxic epidermal necrolysis
Urgent dermatology consultation and skin biopsy
No mucosal involvement, superficial peeling, positive Nikolsky sign
▶
Clinical diagnosis of SSSS favored
Treat empirically while confirming focus of infection
Adults presenting with SSSS features
▶
Search for underlying renal failure or immunosuppression
Higher mortality 40 to 63%; ICU level monitoring warranted
Monitoring and targets
Monitoring bundle
▶
Temperature monitoring every 2 to 4 hours
▶
Thermoregulation impaired with large denuded areas
Warming blankets or heated environment for neonates
Fluid balance
▶
Urine output target 1 to 2 mL/kg/hour in children
Daily weights in neonates
Skin progression assessment
▶
BSA involvement estimation at presentation and 24 hours
New blister formation or spread tracking
Escalation triggers
▶
Failure to improve within 36 to 48 hours of appropriate antibiotics
▶
Reassess antibiotic coverage for MRSA
Reconsider diagnosis and obtain skin biopsy
Hemodynamic deterioration
▶
SBP < 90 mmHg in adults or age-based thresholds in children
Escalate to ICU level care
Worsening fluid balance or renal function
▶
Dose-adjust antibiotics
Nephrology consultation in adults with renal insufficiency
Immediate consults
Consultation triggers
▶
Dermatology
▶
Diagnostic uncertainty, especially TEN vs SSSS
Skin biopsy planning and wound care guidance
Pediatric surgery or burn team
▶
Extensive skin breakdown requiring specialized wound care
BSA involvement > 30%
Infectious diseases
▶
MRSA concern or failure of initial therapy
Immunocompromised patients and adults with high mortality risk
History
Presentation pattern
Prodromal features
▶
Fever, irritability, and malaise
▶
Preceding blistering by 24 to 48 hours
Out-of-proportion skin tenderness early
Skin pain and tenderness
▶
Exquisite cutaneous sensitivity
Often precedes visible blistering
Skin progression sequence
▶
Erythema beginning in skin folds and periorificial areas
Flaccid bullae formation
Widespread superficial desquamation in head-to-toe direction
Preceding infection source
▶
Impetigo or skin infection
▶
Crusted lesions at site of primary infection
Often remote from site of desquamation
Conjunctivitis
▶
Purulent eye discharge
Periorbital erythema
Upper respiratory infection
▶
Recent URI, sore throat, or otitis
Rhinorrhea or cough
Wound or surgical site infection
Umbilical stump infection in neonates
Perianal infection
Risk factors
Host susceptibility
▶
Age < 6 years
▶
Highest risk in infants < 2 years (~45 per million annual incidence)
Immature renal clearance of exfoliative toxins
Lack of neutralizing anti-toxin antibodies
Neonates < 1 month
▶
Higher dehydration risk
Temperature dysregulation
Secondary infection risk
Atopic dermatitis in children
▶
Reported in 5 to 15% of pediatric SSSS cases
Disrupted skin barrier increases susceptibility
Adult risk factors
▶
Renal insufficiency
▶
Impaired toxin clearance
Adult mortality 40 to 63%
Immunosuppression
▶
HIV or AIDS
Malignancy or chemotherapy
Organ transplant recipients
Environmental and social factors
▶
Daycare or household contact with skin infections
▶
Impetigo or boils in contacts
Prior MRSA colonization in household
Seasonal pattern
▶
Higher incidence in summer and autumn
Crowded living conditions or poor hygiene
Medication history
Medications to review
▶
Recent sulfonamides, anticonvulsants, or antibiotics
▶
Drug-induced TEN must be excluded
History of prior drug reactions
IVIG use in recurrent cases
▶
Recent evidence does not support routine use
Prolonged hospitalization associated with IVIG
Corticosteroid use
▶
May worsen SSSS if erroneously given
Contraindicated in SSSS
Physical Exam
Vitals and general
Hemodynamic stability snapshot
▶
Temperature
▶
Fever common but not universal
Hypothermia in neonates suggests instability
Heart rate
▶
Tachycardia most common vital sign abnormality
True septic shock pattern is atypical for uncomplicated SSSS
Blood pressure
▶
Usually within normal limits in uncomplicated pediatric cases
Hypotension as marker of secondary sepsis or fluid deficit
Respiratory rate
▶
Elevation may indicate pain, fever, or secondary pneumonia
General appearance
▶
Irritability and inconsolability
▶
Skin pain elicited with minimal handling
Refusal to be touched
Hydration status
▶
Dry mucous membranes
Decreased skin turgor over uninvolved areas
Skin examination
Characteristic skin findings
▶
Diffuse tender erythema
▶
Beginning in flexural folds (axillae, groin, neck)
Periorificial distribution around mouth, eyes, and nose
Flaccid thin-walled bullae
▶
Easily ruptured
Superficial, not tense
Widespread desquamation
▶
Superficial peeling with scalded appearance
Epidermis slides off in sheets
Nikolsky sign
▶
Positive in SSSS
▶
Lateral pressure on uninvolved skin causes superficial epidermis to shear
Reflects split at stratum granulosum level
Absent in bullous impetigo (which is localized)
Periorificial findings
▶
Radial fissuring and crusting around mouth
▶
Classic and highly suggestive of SSSS
Perinasal and periocular crusting common
Mucous membranes spared
▶
No intraoral erosions
Absence of mucosal involvement distinguishes from TEN
Primary infection source identification
Focal infection assessment
▶
Conjunctivae
▶
Purulent discharge
Periorbital erythema
Nares and oropharynx
▶
Nasopharyngeal colonization as source
Pharyngeal erythema
Umbilicus in neonates
▶
Omphalitis signs
Periumbilical erythema and discharge
Perianal area
▶
Erythema or visible infection
Wounds and surgical sites
PITFALLS
Diagnostic pitfalls
▶
Missing TEN diagnosis
▶
Any mucosal involvement should raise concern
Skin biopsy required if clinical doubt
Treating adults as uncomplicated pediatric SSSS
▶
Much higher mortality in adults
Underlying conditions must be actively sought
Overdiagnosing SSSS in drug-exposed patients
▶
Thorough medication history mandatory
Patch testing or biopsy may be needed
Differential Diagnosis
Life-threatening mimics
Toxic epidermal necrolysis
▶
ICD-10 L51.2
▶
Drug exposure history required
Mucosal involvement present
Full-thickness epidermal necrosis on biopsy
▶
Subepidermal cleavage plane
Necrotic keratinocytes
Mortality 20 to 30% in adults
Stevens-Johnson syndrome
▶
ICD-10 L51.1
▶
Drug-related, target lesions
Mucosal erosions
Epidermal detachment < 10% BSA
▶
Overlap with TEN at 10 to 30% BSA
Staphylococcal sepsis with skin findings
▶
ICD-10 A41.01
▶
Hemodynamic instability distinguishes
Blood cultures positive
Localized vs disseminated staphylococcal disease
Bullous impetigo
▶
ICD-10 L01.03
▶
Same toxin mechanism, localized to infection site
No positive Nikolsky sign at distant sites
Does not spread beyond primary lesion
Impetigo (non-bullous)
▶
ICD-10 L01.01
▶
Superficial crusting without systemic toxin effect
Honey-colored crusts
Other blistering and exfoliating eruptions
Pemphigus foliaceus
▶
ICD-10 L10.2
▶
Targets desmoglein 1 (same as SSSS exfoliative toxins)
Chronic course with positive direct immunofluorescence
Autoimmune; not infectious
Scarlet fever
▶
ICD-10 A38.9
▶
Sandpaper rash with pharyngitis
No bullae or positive Nikolsky sign
Kawasaki disease
▶
ICD-10 M30.3
▶
Prolonged fever, conjunctival injection, mucositis
Desquamation in convalescent phase only
Acute generalized exanthematous pustulosis
▶
ICD-10 L27.0
▶
Drug-related
Subcorneal pustules without Nikolsky sign
Epidermolysis bullosa
▶
ICD-10 Q81.9
▶
Genetic; onset from birth
No infectious source
Thermal burns and child abuse
▶
Distribution and history help distinguish
▶
Fixed margins vs dynamic spread
Mechanism inconsistency
Laboratory Tests
Microbiological studies
Bacterial cultures from infection foci
▶
Swabs from conjunctivae, nasopharynx, perioral, perianal, wounds, umbilicus
▶
Higher yield than blood cultures
Identifies toxin-producing Staphylococcus aureus
Sensitivity and antibiotic susceptibility testing
▶
Identifies MRSA requiring vancomycin
High clindamycin resistance rates (52 to 85%) in SSSS isolates
Skin swab from blister base
▶
Lower yield than focal infection site swabs
Toxin is produced remotely; blisters are sterile
Blood cultures
▶
Routine blood cultures not recommended in healthy children
▶
Typically sterile in uncomplicated pediatric SSSS
Risk of false-positive results and overtreatment
Indicated in adults, immunocompromised, or sepsis features
▶
Two sets prior to antibiotics when feasible
Positive blood cultures prompt broader sepsis workup
Routine blood work
Complete blood count
▶
Leukocytosis common but non-specific
▶
Does not alter diagnosis or management in typical pediatric cases
2025 systematic review: routine labs do not improve outcomes in SSSS
Leukopenia as marker of severe illness or secondary sepsis
Metabolic panel and renal function
▶
Electrolytes for dehydration and fluid replacement guidance
▶
Sodium, potassium correction targets
Creatinine and BUN
▶
Renal function critical in adults (toxin clearance)
Antibiotic dose adjustment for impairment
CRP and inflammatory markers
▶
Non-specific in SSSS
▶
Limited diagnostic value for SSSS specifically
May support extent of systemic inflammation
TEN exclusion labs
Complete blood count with differential for TEN concern
▶
Lymphopenia associated with SJS and TEN
▶
Absence of lymphopenia supports SSSS over TEN
Eosinophilia may suggest drug hypersensitivity reaction
Liver function tests when TEN possible
▶
Hepatic involvement in SJS/TEN
Not expected in SSSS
Diagnostic Tests
Scoring Systems
No validated disease-specific scoring tool for SSSS
▶
Clinical diagnosis based on history and examination
▶
Abrupt onset, skin tenderness, positive Nikolsky sign
Periorificial distribution, mucous membrane sparing
BSA involvement estimation used for fluid management
▶
Rule of Nines adapted for age in pediatric patients
Lund-Browder chart for more precise pediatric BSA estimation
Severity stratification for disposition
▶
Mild: limited BSA, tolerating oral intake, hemodynamically stable
▶
Outpatient or short observation possible in reliable families
Moderate: moderate BSA, dehydration, unable to maintain intake
▶
Inpatient admission required
Severe: extensive BSA, sepsis features, adult presentation
▶
ICU-level care; consult burn team
MRI
MRI role in SSSS
▶
No routine MRI indication for uncomplicated SSSS
▶
Diagnosis is clinical and microbiological
Imaging not required to confirm superficial epidermal split
Potential use in deep-seated infection identification
▶
Osteomyelitis or septic arthritis as concurrent source
Necrotizing fasciitis exclusion in atypical presentations
Limitations
▶
Availability and patient cooperation
Not first-line for soft tissue infection in this context
CT
CT imaging indications
▶
Chest CT if pneumonia complication suspected
▶
Respiratory distress not explained by examination
European Academy of Dermatology: pneumonia is a feared complication of adult SSSS
Abdomen/pelvis CT for deep infection source in adults
▶
Internal abscess or undrained focus driving persistent toxin production
Failure to improve despite appropriate antibiotics
Head CT in altered mental status
▶
Meningitis or brain abscess exclusion
Rare complication of invasive staphylococcal disease
CT limitations in SSSS
▶
Radiation exposure especially relevant in young children
▶
Not indicated routinely
Skin and soft tissue diagnosis remains clinical
Ultrasound
Point-of-care ultrasound applications
▶
IV access guidance
▶
Avoid denuded skin sites
Ultrasound-guided peripheral or central access
Soft tissue ultrasound
▶
Cellulitis vs abscess at primary infection site
Drainage planning for loculated collections
Lung ultrasound
▶
Consolidation pattern if pneumonia complication suspected
▶
Tissue-like echotexture
Reduces radiation in pediatric patients
Pleural effusion identification
▶
Rare complication of secondary bacterial pneumonia
Skin biopsy planning adjunct
▶
Ultrasound guidance not typically needed for superficial biopsy
May assist if subcutaneous abscess adjacent to biopsy site
Disposition
Admission indications
Inpatient admission criteria
▶
Inability to maintain oral hydration
▶
Perioral pain limiting fluid intake
Vomiting or marked refusal
Extensive BSA involvement
▶
Significant insensible losses requiring IV fluid management
Wound care needs exceeding home capability
Neonates and young infants
▶
Age < 3 months
Higher risk of temperature dysregulation and secondary infection
All adults with SSSS
▶
Mortality 40 to 63%
Comorbidity management required
ICU-level care indications
▶
Sepsis or hemodynamic instability
▶
Vasopressor requirement
Lactate >= 2 mmol/l with clinical deterioration
Extensive skin failure
▶
BSA involvement comparable to major burn
Requires burn unit expertise
Adult patients with comorbid renal failure or immunosuppression
▶
Rapid clinical deterioration possible
Discharge criteria
Copy
Outpatient eligibility criteria
▶
Hemodynamically stable
▶
Normal vital signs for age
No tachycardia at rest
Tolerating adequate oral fluids and medications
▶
Demonstrating improved perioral pain
Limited BSA involvement with contained wound care needs
▶
Family capable of wound dressing changes
Reliable follow-up confirmed
Antibiotics transitioned to oral route
▶
Clinical improvement on IV antibiotics prior to transition
Follow-up plan
▶
Physician follow-up within 24 to 48 hours
▶
Assess wound healing and antibiotic response
Dermatology follow-up for complicated cases
▶
Recurrent SSSS or underlying skin conditions
Neonatology follow-up for discharged neonates
Treatment
Antibiotic therapy
First-line: IV beta-lactam
▶
Cefazolin IV preferred over nafcillin/oxacillin
▶
25 to 33 mg/kg/dose IV every 8 hours (pediatric)
1 to 2 g IV every 8 hours (adult)
Fewer infusion-related adverse effects than nafcillin
Class I recommendation for anti-staphylococcal coverage
Oxacillin or nafcillin IV if cefazolin unavailable
▶
Nafcillin 150 to 200 mg/kg/day divided every 6 hours (pediatric)
Phlebitis risk requires adequate dilution and slow infusion
MRSA coverage indications
▶
Vancomycin IV
▶
15 mg/kg/dose IV every 6 hours (pediatric; adjust to target AUC/MIC)
15 to 20 mg/kg IV every 8 to 12 hours (adult)
Trough or AUC-guided monitoring per institutional protocol
Indication: high local MRSA prevalence, prior MRSA colonization, failure of beta-lactam
Clindamycin: not recommended
▶
High resistance rates in SSSS isolates (52 to 85%)
Systematic review: no outcome benefit despite anti-toxin theory
Oral step-down when clinically improved
▶
Cephalexin PO
▶
25 to 50 mg/kg/day divided every 6 to 8 hours (pediatric)
500 mg PO every 6 hours (adult)
Dicloxacillin PO
▶
25 mg/kg/day divided every 6 hours (pediatric)
500 mg PO every 6 hours (adult)
Duration: 7 to 10 days total course in uncomplicated cases
Fluid management
IV fluid resuscitation
▶
Crystalloid IV replacement for burn-like losses
▶
Lactated Ringer's or 0.9% NaCl
Maintenance plus estimated losses from denuded skin
Electrolyte correction
▶
Sodium and potassium monitoring daily
Adjust based on ongoing losses
Transition to oral fluids when perioral pain improving
▶
Cool liquids and soft foods better tolerated
Avoid acidic or hot foods
Wound and skin care
Skin barrier protection
▶
Gentle non-adherent dressings over denuded areas
▶
Avoid adhesive dressings on fragile skin
Petrolatum gauze or silicone-based wound dressings
Skin care technique
▶
Minimal friction during bathing and dressing changes
Emollient application to intact but erythematous areas
Temperature management
▶
Warm environment to compensate for heat loss
Particularly critical for neonates
Primary infection source treatment
▶
Conjunctivitis: topical antibiotic eye drops
▶
Tobramycin or polymyxin-trimethoprim ophthalmic drops
Impetigo lesions: wound care and systemic antibiotic covers both
Perianal or periumbilical: local hygiene and systemic coverage
Analgesics and supportive agents
Pain management
▶
Acetaminophen
▶
15 mg/kg/dose PO or PR every 4 to 6 hours (pediatric)
500 to 1000 mg PO every 6 hours (adult)
Maximum 75 mg/kg/day or 4 g/day
Ibuprofen when renal function normal
▶
10 mg/kg/dose PO every 6 to 8 hours (pediatric)
400 to 600 mg PO every 6 to 8 hours (adult)
Opioid analgesics for severe skin pain
▶
Morphine 0.1 mg/kg IV PRN for procedural pain (pediatric)
Careful titration to respiratory status
Agents to avoid
▶
Corticosteroids: contraindicated
▶
Immunosuppressive; may worsen infection
Can accelerate skin breakdown
IVIG: not routinely recommended
▶
Recent evidence associates use with prolonged hospitalization
Reserve for refractory or immunocompromised cases under specialist guidance
Special Populations
Pregnancy
Pregnancy-specific considerations
▶
SSSS in pregnancy is rare; usually adult risk factors apply
▶
Immunological changes of pregnancy may alter susceptibility
Exfoliative toxin clearance may be altered by pregnancy-related renal physiology
Antibiotic selection in pregnancy
▶
Cefazolin: safe in all trimesters
▶
Preferred first-line IV agent
Oxacillin: generally considered safe but limited data
Vancomycin if MRSA suspected
▶
Monitor renal function and drug levels
Avoid clindamycin given resistance data
Fetal monitoring
▶
Maternal fever and systemic illness require fetal heart rate monitoring
Viable gestation warrants obstetric consultation
Wound care adaptation
▶
Positioning considerations to avoid supine hypotension
Fluid resuscitation targets adjusted for pregnancy physiology
Geriatric
Older adult features
▶
Adult SSSS mortality 40 to 63% due to comorbidities
▶
Renal insufficiency impairs exfoliative toxin clearance
Immunosenescence reduces anti-toxin antibody response
Antibiotic dosing adjustments
▶
Cefazolin: renally dose-adjusted
▶
CrCl 10 to 30 mL/min: 1 g IV every 12 hours
Vancomycin: AUC-guided monitoring essential
▶
Renal toxicity risk higher in older adults
Comorbidity management
▶
Cardiac monitoring for QT prolongation risk with any fluoroquinolone
Pressure injury prevention given immobility from pain
Fluid management caution
▶
Avoid fluid overload in heart failure or renal disease
Assess baseline renal and cardiac function before aggressive resuscitation
Disposition
▶
Low threshold for ICU admission
Palliative care discussion if poor baseline functional status
Pediatrics
Pediatric-specific features
▶
SSSS is predominantly a pediatric disease
▶
Annual incidence ~7.67 per million U.S. children
Highest rates in infants < 2 years (~45 per million)
Pediatric mortality ~0.3%
Weight-based antibiotic dosing
▶
Cefazolin 25 to 33 mg/kg/dose IV every 8 hours
▶
Maximum single dose 2 g
Cephalexin 25 to 50 mg/kg/day PO divided every 6 to 8 hours (oral step-down)
▶
Maximum 4 g/day
Vancomycin 15 mg/kg/dose IV every 6 hours if MRSA
▶
AUC/MIC-guided dosing per institutional protocol
Neonatal considerations
▶
Age < 1 month highest risk for temperature dysregulation and fluid loss
Neonatology consultation for hospitalized neonates
Umbilical venous catheter for IV access when peripheral access fails
Oral intake limitation
▶
Perioral crusting and pain limit feeding
IV fluids until oral route established
Nasogastric tube for medication delivery if needed
Child protection screening
▶
Recurrent SSSS or atypical presentation requires safeguarding review
Assess for adequate supervision and hygiene conditions
Background
Epidemiology
Incidence and demographic distribution
▶
Annual incidence approximately 7.67 per million U.S. children
▶
British Journal of Dermatology epidemiologic data
Highest rates in infants < 2 years: ~45 per million
Seasonal pattern
▶
Higher incidence in summer and autumn
Mirrors impetigo seasonality
Sex and race distribution
▶
Female sex slightly more common
Lower rates in Black children compared to White children
Mortality
▶
Pediatric mortality approximately 0.3%
▶
Excellent prognosis with prompt treatment
Adult mortality 40 to 63%
▶
Driven by underlying comorbidities
Renal failure and immunosuppression key contributors
Pathophysiology
Toxin-mediated mechanism
▶
Exfoliative toxins A and B (ETA and ETB)
▶
Produced by phage group II Staphylococcus aureus
ETA encoded on bacterial chromosome
ETB encoded on plasmid
Target: desmoglein 1
▶
Serine protease activity cleaves desmoglein 1
Same target as pemphigus foliaceus autoantibodies
Desmoglein 1 expressed in superficial epidermis
Result: intraepidermal split at stratum granulosum
▶
Superficial cleavage (vs subepidermal in TEN)
Acantholysis without keratinocyte necrosis
Why children are predominantly affected
▶
Immature renal clearance of exfoliative toxins
▶
Toxins are renally excreted
Accumulate to pathological levels at lower bacterial burden
Lack of neutralizing anti-ETA/ETB antibodies
▶
Seroconversion occurs with age
Adults with impaired immunity or renal failure cannot clear toxins
Remote toxin effect
▶
Primary infection site remote from blistering skin
▶
Toxin enters bloodstream and acts on entire skin surface
Blister fluid is sterile
Skin biopsy from blister not expected to grow Staphylococcus
Therapeutic Considerations
Antibiotic principles
▶
Anti-staphylococcal beta-lactam is cornerstone
▶
Eliminates toxin-producing bacteria at primary focus
Cefazolin preferred for IV therapy
MRSA coverage based on risk stratification not routine
▶
High local MRSA prevalence or prior MRSA history
Failure after 36 to 48 hours of beta-lactam
Clindamycin rationale vs evidence
▶
Theoretically inhibits toxin production
Systematic review evidence does not support improved outcomes
High resistance rates make it unreliable
Wound care philosophy
▶
Skin will re-epithelialize rapidly with source control
▶
Usually complete healing within 7 to 14 days
No debridement required
Minimize trauma to fragile skin
▶
Non-adherent dressings
Gentle handling during all care
Prognosis factors
▶
Time to antibiotic therapy
▶
Early treatment correlates with faster healing
Identification and control of primary infection source
▶
Essential for toxin elimination
Absence of mucosal involvement confirms favorable SSSS prognosis over TEN
Patient Discharge Instructions
copy discharge instructions
Copy
Skin care at home
▶
Gentle sponge baths with lukewarm water
▶
Avoid scrubbing or rubbing peeling skin
Pat dry gently with soft towel
Apply prescribed emollient or wound dressing as instructed
▶
Keep denuded areas covered to prevent secondary infection
Change dressings daily or as directed
Avoid harsh soaps, perfumed products, and adhesive bandages on healing skin
Medications
▶
Complete the full course of antibiotics even if skin looks better
▶
Do not stop early
Give pain reliever as directed for skin discomfort
▶
Acetaminophen or ibuprofen as recommended by your doctor
Do not use any steroid creams unless specifically prescribed
Feeding and hydration
▶
Cool, soft foods and liquids are easiest with mouth sores
▶
Popsicles, yogurt, cool soup
Ensure adequate fluid intake
▶
Monitor wet diapers in infants (at least 4 per day)
Return to ER warning signs
▶
New blistering or skin peeling spreading
Fever persisting or returning after 48 hours of antibiotics
Child refusing all fluids or showing signs of dehydration
▶
Dry mouth, no tears, no wet diapers in 8 hours
Skin looks infected with increasing redness, warmth, or pus
Difficulty breathing
Child becoming very sleepy or hard to wake
Mucosal involvement: ulcers inside the mouth or eye
Follow-up
▶
Physician appointment within 24 to 48 hours of discharge
Return to daycare or school when skin is healed and antibiotics are complete
▶
Discuss timing with your physician
Notify daycare or school contacts to check children for similar skin infections
References
Guidelines and key sources
Primary clinical references
▶
Pediatric Emergency Care systematic review on SSSS management
▶
Routine blood cultures and routine labs not recommended in healthy pediatric patients
British Journal of Dermatology epidemiologic study
▶
Annual incidence 7.67 per million; highest in infants < 2 years
European Academy of Dermatology and Venereology adult SSSS review
▶
Adult mortality 40 to 63%; IVIG not routinely recommended
Pediatric Dermatology systematic review on antibiotic selection
▶
Clindamycin not recommended due to resistance and lack of outcome benefit
Cefazolin preferred over nafcillin for IV therapy
Evidence and coding
Pathophysiology references
▶
NEJM review on exfoliative toxin mechanism and TEN differentiation
▶
Subepidermal vs intraepidermal cleavage plane biopsy findings
Mucosal involvement distinguishes TEN from SSSS
Pediatric Dermatology review on desmoglein 1 cleavage
▶
ETA and ETB serine protease mechanism
Coding standards
▶
ICD-10 L00 staphylococcal scalded skin syndrome
ICD-10 L51.2 toxic epidermal necrolysis (key differential)
ICD-10 L01.03 bullous impetigo (localized form of same toxin mechanism)
SNOMED CT staphylococcal scalded skin syndrome disorder concept
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.
← Management Protocols
Home
Management Protocols
Staphylococcal Scalded Skin Syndrome